Carson Wealth (CWM LLC)’s VanEck Pharmaceutical ETF PPH Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$49.5K	Sell	476 -35	-7%	-$3.73K	﹤0.01%	3820
2025 Q4	$53K	Buy	511 +136	+36%	+$13.2K	﹤0.01%	3564
2025 Q3	$34K	Hold	375	–	–	﹤0.01%	3805
2025 Q2	$33K	Buy	375 +235	+168%	+$20.4K	﹤0.01%	3591
2025 Q1	$13K	Buy	140 +76	+119%	+$6.84K	﹤0.01%	3966
2024 Q4	$6K	Hold	64	–	–	﹤0.01%	4143
2024 Q3	$6K	Sell	64 -539	-89%	-$51.2K	﹤0.01%	4034
2024 Q2	$55K	Buy	+603	New	+$53.8K	﹤0.01%	2416
2018 Q2	–	Sell	-400	Closed	-$23K	–	1755
2018 Q1	$23K	Hold	400	–	–	﹤0.01%	687
2017 Q4	$24K	Hold	400	–	–	﹤0.01%	669
2017 Q3	$23K	Hold	400	–	–	﹤0.01%	679
2017 Q2	$24K	Buy	400 +310	+344%	+$17.5K	﹤0.01%	611
2017 Q1	$5K	Hold	90	–	–	﹤0.01%	871
2016 Q4	$5K	Hold	90	–	–	﹤0.01%	860
2016 Q3	$5K	Hold	90	–	–	﹤0.01%	834
2016 Q2	$5K	Buy	+90	New	+$5.25K	﹤0.01%	633

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

BCIM

British Columbia Investment Management Victoria, British Columbia, Canada $16B AUM 37.57% 1-Year Est. Return

ERSOT

Employees Retirement System of Texas Austin, Texas $12.6B AUM 31.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

Carson Wealth (CWM LLC)'s PPH Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its VanEck Pharmaceutical ETF (PPH) stake by 6.8% in Q1 2026, selling an estimated $3.73K and leaving 476 shares worth $49.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3820.

Carson Wealth (CWM LLC) first reported a position in PPH in Q2 2016 and has held it in 16 quarters since. The position peaked at $55K in Q2 2024. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

Carson Wealth (CWM LLC) held 476 shares of VanEck Pharmaceutical ETF worth $49.5K as of Q1 2026.
Carson Wealth (CWM LLC) sold 35 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $3.73K.
VanEck Pharmaceutical ETF made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3820 holding.
Carson Wealth (CWM LLC) first reported a position in VanEck Pharmaceutical ETF in Q2 2016 and has held it in 16 quarters since.
Carson Wealth (CWM LLC)'s VanEck Pharmaceutical ETF position peaked at $55K in Q2 2024.
147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.